Delaware | 001-34827 | 27-2301797 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
5619 Denver Tech Center Parkway, Suite 1000, Greenwood Village, CO | 80,111 | |
(Address of principal executive offices) | (Zip Code) |
Exhibit Number | Description | ||
99.1 | Press Release issued by Molycorp, Inc. on November 8, 2012 |
MOLYCORP, INC. | ||
By: | /s/ Michael F. Doolan | |
Name: | Michael F. Doolan | |
Title: | Chief Financial Officer | |
Date: November 8, 2012 |
Exhibit Number | Description | ||
99.1 | Press Release issued by Molycorp, Inc. on November 8, 2012 |
• | Molycorp continues to ramp up Project Phoenix operations at its Mountain Pass, California, facility, and it remains on schedule to achieve a Phase 1 operational rate of 19,050 metric tons (mt) per year in the fourth quarter of 2012. To date, 80% of Project Phoenix facilities are at Phase 1 or greater than Phase 1 operational capabilities. |
• | The Company reported revenue of $205.6 million in the third quarter of 2012, a 49% year-over-year increase and a 97% increase over the previous quarter. It also generated positive operating cash flow in Q3 of $17.2 million. |
• | The Company sold 4,391 mt of product across its business segments in the third quarter of 2012, including: 2,768 mt of rare earth oxide equivalent products at an average sales price of $43.45 per kilogram (kg); 1,527 mt of bonded magnet powders and alloys at an average sales price of $48.98 per kg; and 96 mt of rare metals at an average sales price of $269.22 per kg. |
• | The Company reported a net loss of $0.19 per share, and a loss of $0.05 on an adjusted non-GAAP earnings per share basis, taking into account operational expansion items, out-of-ordinary business expenses, and certain non-cash items. |
September 30, 2012 | December 31, 2011 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 436,025 | $ | 418,855 | |||
Trade accounts receivable, net | 88,471 | 70,679 | |||||
Inventory | 281,133 | 111,943 | |||||
Deferred charges | 12,517 | 7,318 | |||||
Deferred tax assets | 17,402 | — | |||||
Income tax receivable | 38,933 | 10,514 | |||||
Prepaid expenses and other current assets | 48,711 | 19,735 | |||||
Total current assets | 923,192 | 639,044 | |||||
Non-current assets: | |||||||
Deposits | 23,287 | 23,286 | |||||
Property, plant and equipment, net | 1,363,444 | 561,628 | |||||
Inventory | 9,601 | 4,362 | |||||
Intangible assets, net | 479,173 | 3,072 | |||||
Investments | 68,006 | 20,000 | |||||
Deferred tax assets | 10,298 | — | |||||
Goodwill | 505,003 | 3,432 | |||||
Other non-current assets | 5,322 | 301 | |||||
Total non-current assets | 2,464,134 | 616,081 | |||||
Total assets | $ | 3,387,326 | $ | 1,255,125 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Trade accounts payable | $ | 230,255 | $ | 161,587 | |||
Accrued expenses | 66,289 | 12,898 | |||||
Income tax payable | 25,601 | — | |||||
Deferred tax liabilities | 128 | 1,356 | |||||
Debt and capital lease obligations | 32,935 | 1,516 | |||||
Other current liabilities | 2,096 | 1,266 | |||||
Total current liabilities | 357,304 | 178,623 | |||||
Non-current liabilities: | |||||||
Asset retirement obligation | 20,727 | 15,145 | |||||
Deferred tax liabilities | 189,894 | 18,899 | |||||
Debt and capital lease obligations | 1,183,528 | 196,545 | |||||
Derivative liability | 8,846 | — | |||||
Pension liabilities | 2,855 | — |
September 30, 2012 | December 31, 2011 | ||||||
Other non-current liabilities | 3,020 | 683 | |||||
Total non-current liabilities | 1,408,870 | 231,272 | |||||
Total liabilities | $ | 1,766,174 | $ | 409,895 | |||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock, $0.001 par value; 350,000,000 shares authorized at September 30, 2012 | 138 | 84 | |||||
Preferred stock, $0.001 par value; 5,000,000 shares authorized at September 30, 2012 | 2 | 2 | |||||
Additional paid-in capital | 1,686,226 | 838,547 | |||||
Accumulated other comprehensive loss | (9,646 | ) | (8,481 | ) | |||
(Deficit) retained earnings | (74,898 | ) | 15,078 | ||||
Total Molycorp stockholders’ equity | 1,601,822 | 845,230 | |||||
Noncontrolling interests | 19,330 | — | |||||
Total stockholders’ equity | 1,621,152 | 845,230 | |||||
Total liabilities and stockholders’ equity | $ | 3,387,326 | $ | 1,255,125 |
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | ||||||||||||||
2012 | 2011 | 2012 | 2011 | ||||||||||||
Sales | $ | 205,604 | $ | 138,050 | $ | 394,651 | $ | 263,927 | |||||||
Costs of sales: | |||||||||||||||
Costs excluding depreciation and amortization | (184,128 | ) | (50,602 | ) | (337,769 | ) | (105,670 | ) | |||||||
Depreciation and amortization | (10,612 | ) | (5,056 | ) | (19,065 | ) | (9,588 | ) | |||||||
Gross profit | 10,864 | 82,392 | 37,817 | 148,669 | |||||||||||
Operating expenses: | |||||||||||||||
Selling, general and administrative | (31,468 | ) | (12,182 | ) | (78,721 | ) | (31,465 | ) | |||||||
Corporate development | (1,073 | ) | (573 | ) | (19,379 | ) | (3,889 | ) | |||||||
Depreciation, amortization and accretion | (9,723 | ) | (544 | ) | (12,361 | ) | (1,384 | ) | |||||||
Research and development | (8,929 | ) | (2,148 | ) | (18,628 | ) | (5,165 | ) | |||||||
Operating (loss) income | (40,329 | ) | 66,945 | (91,272 | ) | 106,766 | |||||||||
Other income (expense): | |||||||||||||||
Other expense | (57 | ) | (117 | ) | (37,615 | ) | (152 | ) | |||||||
Foreign exchange gains (losses), net | 1,910 | (2,000 | ) | 724 | (1,850 | ) | |||||||||
Interest expense, net | (5,269 | ) | (671 | ) | (14,989 | ) | (461 | ) | |||||||
(3,416 | ) | (2,788 | ) | (51,880 | ) | (2,463 | ) | ||||||||
(Loss) income before income taxes and equity earnings | (43,745 | ) | 64,157 | (143,152 | ) | 104,303 | |||||||||
Income tax benefit (expense) | 28,956 | (19,056 | ) | 58,442 | (12,643 | ) | |||||||||
Equity in results of affiliates | (662 | ) | — | (1,146 | ) | — | |||||||||
Net (loss) income | (15,451 | ) | 45,101 | (85,856 | ) | 91,660 | |||||||||
Net (income) loss attributable to noncontrolling interest | (3,440 | ) | 255 | (4,120 | ) | (713 | ) | ||||||||
Net (loss) income attributable to Molycorp stockholders | $ | (18,891 | ) | $ | 45,356 | $ | (89,976 | ) | $ | 90,947 | |||||
Net (loss) income | $ | (15,451 | ) | $ | 45,101 | $ | (85,856 | ) | $ | 91,660 | |||||
Other comprehensive income: | |||||||||||||||
Foreign currency translation adjustments | 526 | (5,564 | ) | (1,165 | ) | (4,240 | ) | ||||||||
Comprehensive (loss) income | $ | (14,925 | ) | $ | 39,537 | $ | (87,021 | ) | $ | 87,420 | |||||
Comprehensive (loss) income attributable to: | |||||||||||||||
Molycorp stockholders | (11,485 | ) | 40,346 | (82,901 | ) | 87,130 | |||||||||
Noncontrolling interest | (3,440 | ) | (809 | ) | (4,120 | ) | 290 | ||||||||
$ | (14,925 | ) | $ | 39,537 | $ | (87,021 | ) | $ | 87,420 | ||||||
(Loss) income per share of common stock (Table 5): | |||||||||||||||
Basic | $ | (0.19 | ) | $ | 0.51 | $ | (0.97 | ) | $ | 1.01 | |||||
Diluted | $ | (0.19 | ) | $ | 0.49 | $ | (0.97 | ) | $ | 1.00 |
Nine months ended | |||||||
September 30, 2012 | September 30, 2011 | ||||||
Cash flows from operating activities: | |||||||
Net (loss) income | $ | (85,856 | ) | $ | 91,660 | ||
Adjustments to reconcile net (loss) income to net cash from operating activities: | |||||||
Depreciation, amortization and accretion | 31,426 | 10,972 | |||||
Deferred income tax benefit | (35,179 | ) | (4,544 | ) | |||
Inventory write-downs | 41,082 | 1,585 | |||||
Release of inventory step-up value | 26,428 | 10,200 | |||||
Stock-based compensation expense | 3,179 | 4,042 | |||||
Amortization of debt discount | 1,257 | 1,037 | |||||
Allowance for doubtful accounts | 2,500 | — | |||||
Other operating adjustments | 56 | 2,461 | |||||
Net change in operating assets and liabilities | (32,081 | ) | (88,689 | ) | |||
Net cash (used in) provided by operating activities | (47,188 | ) | 28,724 | ||||
Cash flows from investing activities: | |||||||
Cash paid in connection with acquisitions, net of cash acquired | (591,011 | ) | (20,021 | ) | |||
Investment in joint venture | (28,130 | ) | — | ||||
Deposits | (516 | ) | 2,946 | ||||
Cash paid to acquire non-marketable securities | — | (20,000 | ) | ||||
Capital expenditures | (644,683 | ) | (160,917 | ) | |||
Other investing activities | 4,953 | 19 | |||||
Net cash used in investing activities | (1,259,387 | ) | (197,973 | ) | |||
Cash flows from financing activities: | |||||||
Capital contributions | 390,225 | — | |||||
Repayments of short-term borrowings—related party | — | (2,343 | ) | ||||
Repayments of debt | (228,431 | ) | (5,447 | ) | |||
Net proceeds from sale of preferred stock | — | 199,642 | |||||
Net proceeds from sale of common stock | 132,471 | — | |||||
Issuance of 10% Senior Secured Notes | 635,373 | — | |||||
Issuance of 6.00% Convertible Notes | 395,712 | — | |||||
Issuance of 3.25% Convertible Notes | — | 223,100 | |||||
Payments of preferred dividends | (8,539 | ) | (6,167 | ) | |||
Proceeds from debt | 9,456 | 6,337 | |||||
Other financing activities | (3,331 | ) | — | ||||
Net cash provided by financing activities | 1,322,936 | 415,122 | |||||
Effect of exchange rate changes on cash | 809 | (348 | ) | ||||
Net change in cash and cash equivalents | 17,170 | 245,525 | |||||
Cash and cash equivalents at beginning of the period | 418,855 | 316,430 | |||||
Cash and cash equivalents at end of period | $ | 436,025 | $ | 561,955 |
Three months ended September 30, 2012 (In thousands) | Resources | Chemicals and Oxides | Magnetic Materials and Alloys | Rare Metals | Eliminations | Corporate and other | Total Molycorp, Inc. | |||||||||||||||||||||
Sales: | ||||||||||||||||||||||||||||
External | $ | 17,150 | $ | 87,820 | $ | 74,789 | $ | 25,845 | $ | — | $ | 205,604 | ||||||||||||||||
Intersegment | 3,745 | 11,559 | — | — | (15,304 | ) | — | |||||||||||||||||||||
Total sales | $ | 20,895 | $ | 99,379 | $ | 74,789 | $ | 25,845 | $ | (15,304 | ) | $ | 205,604 | |||||||||||||||
Depreciation, amortization and accretion | $ | (4,035 | ) | $ | (5,685 | ) | $ | (8,857 | ) | $ | (1,715 | ) | $ | — | $ | (43 | ) | $ | (20,335 | ) | ||||||||
Operating (loss) income | $ | (23,966 | ) | $ | 2,149 | $ | 1,419 | $ | (3,774 | ) | $ | 369 | $ | (16,526 | ) | $ | (40,329 | ) | ||||||||||
(Loss) income before income taxes and equity earnings | $ | (25,506 | ) | $ | 1,201 | $ | 1,215 | $ | (3,812 | ) | $ | 369 | $ | (17,212 | ) | $ | (43,745 | ) | ||||||||||
Total assets at September 30, 2012 (a) | $ | 1,686,524 | $ | 565,673 | $ | 536,299 | $ | 79,996 | $ | (161,201 | ) | $ | 178,465 | $ | 2,885,756 | |||||||||||||
Capital expenditures | $ | 187,611 | $ | 2,597 | $ | 1,432 | $ | 2,837 | $ | — | $ | 1,387 | $ | 195,864 |
(a) | Excludes goodwill of $501.6 million arising on the Molycorp Canada acquisition which has not been allocated to its operating segments. |
Three Months Ended | ||||||||
(In thousands, except share and per share amounts) | September 30, 2012 | September 30, 2011 | ||||||
Net (loss) income attributable to Molycorp stockholders | $ | (18,891 | ) | $ | 45,356 | |||
Dividends on Convertible Preferred Stock | (2,846 | ) | (2,846 | ) | ||||
(Loss) income attributable to common stockholders | (21,737 | ) | 42,510 | |||||
Weighted average common shares outstanding—basic | 117,086,022 | 83,847,119 | ||||||
Basic (loss) earnings per share | $ | (0.19 | ) | $ | 0.51 | |||
(Loss) income attributable to common stockholders | (21,737 | ) | 42,510 | |||||
Effect of dilutive 3.25% Convertible Notes | — | 404 | ||||||
(Loss) income attributable to common stockholders adjusted for effect of dilution | (21,737 | ) | 42,914 | |||||
Weighted average common shares outstanding—diluted | 117,086,022 | 87,069,256 | ||||||
Diluted (loss) earnings per share | $ | (0.19 | ) | $ | 0.49 |
Nine Months Ended | ||||||||
(In thousands, except share and per share amounts) | September 30, 2012 | September 30, 2011 | ||||||
Net (loss) income attributable to Molycorp stockholders | $ | (89,976 | ) | $ | 90,947 | |||
Dividends on Convertible Preferred Stock | (8,539 | ) | (7,116 | ) | ||||
(Loss) income attributable to common stockholders | (98,515 | ) | 83,831 | |||||
Weighted average common shares outstanding—basic | 101,147,638 | 83,321,816 | ||||||
Basic (loss) earnings per share | $ | (0.97 | ) | $ | 1.01 | |||
(Loss) income attributable to common stockholders | (98,515 | ) | 83,831 | |||||
Effect of dilutive 3.25% Convertible Notes | — | 413 | ||||||
(Loss) income attributable to common stockholders adjusted for effect of dilution | (98,515 | ) | 84,244 | |||||
Weighted average common shares outstanding—diluted | 101,147,638 | 84,596,676 | ||||||
Diluted (loss) earnings per share | $ | (0.97 | ) | $ | 1.00 |
Product Revenues, Volumes | ||||||||
Three Months Ended September 30, | ||||||||
Revenues (in thousands) | 2012 | 2011 | ||||||
Resources (1) | $ | 20,895 | $ | 124,877 | ||||
Chemicals and Oxides (2) | 99,379 | 22,579 | ||||||
Magnetic Materials and Alloys (3) | 74,789 | 14,449 | ||||||
Rare Metals (4) | 25,845 | 13,332 | ||||||
Intersegments eliminations | (15,304 | ) | (37,187 | ) | ||||
Total Net Revenues | $ | 205,604 | $ | 138,050 | ||||
Three Months Ended September 30, | ||||||||
Volumes (in metric tons) | 2012 | 2011 | ||||||
Resources | 835 | 1,002 | ||||||
Chemicals and Oxides | 1,933 | 384 | ||||||
Magnetic Materials and Alloys | 1,527 | 226 | ||||||
Rare Metals | 96 | 88 | ||||||
Intersegments eliminations | (720 | ) | (520 | ) | ||||
Three Months Ended September 30, | ||||||||
Avg Selling Price per kilogram | 2012 | 2011 | ||||||
Resources | $ | 25.02 | $ | 124.65 | ||||
Chemicals and Oxides | $ | 51.41 | $ | 58.79 | ||||
Magnetic Materials and Alloys | $ | 48.98 | $ | 63.95 | ||||
Rare Metals | $ | 269.22 | $ | 151.50 | ||||
1. The Resources segment includes: the Company's operations at its Molycorp Mountain Pass facility where it conducts rare earth minerals extraction to produce rare earth concentrates; REO, including lanthanum, cerium, didymium, neodymium, praseodymium and yttrium; heavy rare earth elements, such as samarium, europium, gadolinium, terbium, dysprosium, and others; didymium rare earth metal; and SorbXTM (formerly XSORBX), a line of proprietary rare earth-based water treatment products. | ||||||||
2. The Chemicals and Oxides division includes: production of REO at the Company's operations in Sillamäe, Estonia; heavy rare earths from the Company's facilities in Jiangyin, Jiangsu Province, China; and production of REO, salts of rare earth elements ("REEs"), zirconium-based engineered materials and mixed rare earth/zirconium oxides from the Company's facilities in Zibo, Shandong Province, China. Rare earths products and zirconium-based engineered products are primarily supplied to the automotive catalyst, electronics, ceramic, clean technology and glass industries. | ||||||||
3. The Magnetic Materials and Alloys segment includes: the production of Neo Powders through Molycorp's wholly-owned manufacturing facilities in Tianjin, China and Korat, Thailand, under the Molycorp Magnequench brand. Neo Powders are used to make bonded magnets for a variety of electronic and mechanical products such as micro motors, precision motors, sensors and other applications requiring high levels of magnetic strength, flexibility, small size and reduced weight. This operating segment also includes manufacturing of neodymium and samarium magnet alloys, other specialty alloy products and rare earth metals at the Company's facility in Tolleson, Arizona. | ||||||||
4. The Rare Metals division includes: Molycorp's production of gallium, indium, tantalum and rhenium from its operations in Quapaw, Oklahoma; Blanding, Utah; Peterborough, Ontario; Napanee, Ontario; Sagard, Germany; and Hyeongok Industrial Zone in South Korea. This operating segment also includes tantalum and niobium from the Company's operations in Sillamäe, Estonia. Rare metals are primarily used in the wireless, light-emitting diode, flat panel display, turbine, solar and catalyst industries. |
(In thousands, except per share data) | Three Months Ended September 30, | |||
2012 | ||||
Net loss attributable to Molycorp stockholders | $ | (18,891 | ) | |
Certain non-cash and other items: | ||||
Stock-based compensation | 1,279 | |||
Inventory write-downs | 14,976 | |||
Impact of purchase accounting on cost of inventory sold | 18,067 | |||
Out of the ordinary items: | ||||
Water removal | 3,174 | |||
Project Phoenix non-capitalizable costs | 4,958 | |||
Business Expansion items: | ||||
Due diligence and other transaction costs | 1,001 | |||
Other business expansion expenses | 1,743 | |||
Release of tax provision | (15,100 | ) | ||
Income tax effect of above adjustments | (14,463 | ) | ||
Adjusted net loss | (3,256 | ) | ||
Dividends on Convertible Preferred Stock | (2,846 | ) | ||
Adjusted net loss attributed to common stockholders for EPS purposes | $ | (6,102 | ) | |
Weighted average shares outstanding | 117,086,022 | |||
Adjusted net loss per share | $ | (0.05 | ) |